IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 31.9618

Change

-0.17 (-0.54)%

Market Cap

N/A

Volume

2.24K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.19 (+0.88%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.33 (+0.56%)

USD 34.45B
DFAC Dimensional U.S. Core Equity 2..

+0.29 (+0.87%)

USD 29.38B
DTB DTE Energy Company 2020 Series

+0.10 (+0.47%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

+0.04 (+0.08%)

USD 25.41B
SGOV iShares® 0-3 Month Treasury B..

+0.06 (+0.06%)

USD 25.27B
GBTC Grayscale Bitcoin Trust (BTC)

+1.11 (+2.39%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

+2.33 (+2.57%)

USD 12.53B
JAAA Janus Detroit Street Trust - J..

+0.02 (+0.04%)

USD 11.98B
DFUV Dimensional US Marketwide Valu..

+0.34 (+0.84%)

USD 10.93B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.14% 49% F 50% F
Dividend Return 0.54% 15% F 11% F
Total Return 6.68% 43% F 43% F
Trailing 12 Months  
Capital Gain 12.24% 54% F 57% F
Dividend Return 0.86% 14% F 11% F
Total Return 13.10% 51% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.33% 72% C 55% F
Dividend Return 4.64% 69% C- 48% F
Total Return 0.31% 18% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 6.90% 65% D 85% B
Risk Adjusted Return 67.29% 80% B- 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.